| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
15,080,000 |
| Market
Cap: |
23.83(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.42 - $2.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
29,258 |
| Total Buy Value |
$0 |
$0 |
$0 |
$67,776 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
476 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Krogulski Kenneth |
Director |
– • – |
2022-06-07 |
4 |
AB |
$2.08 |
$208 |
D/D |
100 |
188,234 |
|
11% |
|
| Galante Joseph C |
Director |
– • – |
2022-06-07 |
4 |
AB |
$2.08 |
$125 |
D/D |
60 |
47,512 |
|
11% |
|
| Young Caroline |
Director |
– • – |
2022-06-06 |
4 |
AB |
$2.07 |
$56 |
D/D |
27 |
16,573 |
|
14% |
|
| Jones James |
Director |
– • – |
2022-06-06 |
4 |
AB |
$2.07 |
$83 |
D/D |
40 |
21,555 |
|
14% |
|
| Krogulski Kenneth |
Director |
– • – |
2022-06-06 |
4 |
AB |
$2.07 |
$282 |
D/D |
136 |
188,134 |
|
14% |
|
| Galante Joseph C |
Director |
– • – |
2022-06-06 |
4 |
AB |
$2.07 |
$168 |
D/D |
81 |
47,452 |
|
14% |
|
| Young Caroline |
Director |
– • – |
2022-06-03 |
4 |
AB |
$2.09 |
$52 |
D/D |
25 |
16,546 |
|
16% |
|
| Jones James |
Director |
– • – |
2022-06-03 |
4 |
AB |
$2.09 |
$79 |
D/D |
38 |
21,515 |
|
16% |
|
| Krogulski Kenneth |
Director |
– • – |
2022-06-03 |
4 |
AB |
$2.09 |
$265 |
D/D |
127 |
187,998 |
|
16% |
|
| Galante Joseph C |
Director |
– • – |
2022-06-03 |
4 |
AB |
$2.09 |
$159 |
D/D |
76 |
47,371 |
|
16% |
|
| Young Caroline |
Director |
– • – |
2022-06-02 |
4 |
AB |
$2.08 |
$52 |
D/D |
25 |
16,521 |
|
18% |
|
| Jones James |
Director |
– • – |
2022-06-02 |
4 |
AB |
$2.08 |
$79 |
D/D |
38 |
21,477 |
|
18% |
|
| Krogulski Kenneth |
Director |
– • – |
2022-06-02 |
4 |
AB |
$2.08 |
$264 |
D/D |
127 |
187,871 |
|
18% |
|
| Galante Joseph C |
Director |
– • – |
2022-06-02 |
4 |
AB |
$2.08 |
$158 |
D/D |
76 |
47,295 |
|
18% |
|
| Young Caroline |
Director |
– • – |
2022-06-01 |
4 |
AB |
$2.05 |
$51 |
D/D |
25 |
16,496 |
|
11% |
|
| Jones James |
Director |
– • – |
2022-06-01 |
4 |
AB |
$2.05 |
$78 |
D/D |
38 |
21,439 |
|
11% |
|
| Krogulski Kenneth |
Director |
– • – |
2022-06-01 |
4 |
AB |
$2.05 |
$260 |
D/D |
127 |
187,744 |
|
11% |
|
| Galante Joseph C |
Director |
– • – |
2022-06-01 |
4 |
AB |
$2.05 |
$156 |
D/D |
76 |
47,219 |
|
11% |
|
| Pavliv Leo |
SVP and Chief Development Off. |
• – – |
2022-05-31 |
4 |
D |
$2.09 |
$70,015 |
D/D |
(33,500) |
129,618 |
|
- |
|
| Galante Joseph C |
Director |
– • – |
2022-05-31 |
4 |
AB |
$2.13 |
$162 |
D/D |
76 |
47,143 |
|
13% |
|
| Jones James |
Director |
– • – |
2022-05-31 |
4 |
AB |
$2.13 |
$81 |
D/D |
38 |
21,401 |
|
13% |
|
| Young Caroline |
Director |
– • – |
2022-05-31 |
4 |
AB |
$2.13 |
$53 |
D/D |
25 |
16,471 |
|
13% |
|
| Krogulski Kenneth |
Director |
– • – |
2022-05-29 |
4 |
AB |
$2.13 |
$271 |
D/D |
127 |
187,617 |
|
13% |
|
| Galante Joseph C |
Director |
– • – |
2022-05-27 |
4 |
AB |
$2.13 |
$162 |
D/D |
76 |
47,067 |
|
12% |
|
| Jones James |
Director |
– • – |
2022-05-27 |
4 |
AB |
$2.13 |
$81 |
D/D |
38 |
21,363 |
|
12% |
|
1400 Records found
|
|
Page 17 of 56 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.05 (3.27%) 
